A Phase 2, Double-blind, Placebo-controlled Study of the Safety and Tolerability of Etanercept in Patients With Alzheimer's Disease.
Phase of Trial: Phase II
Latest Information Update: 01 May 2015
At a glance
- Drugs Etanercept (Primary)
- Indications Alzheimer's disease; Dementia
- Focus Adverse reactions
- Acronyms STEADI-09
- 07 Jun 2017 Biomarkers information updated
- 01 May 2015 Results published in the Neurology.
- 22 Apr 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.